As of Jul 06
| -0.15 / -4.97%|
The 5 analysts offering 12-month price forecasts for Solazyme Inc have a median target of 4.00, with a high estimate of 7.00 and a low estimate of 2.00. The median estimate represents a +39.37% increase from the last price of 2.87.
The current consensus among 6 polled investment analysts is to Hold stock in Solazyme Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.